Login or sign up
For business

Sophiris Bio

4.0ยท 11 reviews
Average ratingGreat
4.0/ 5

Based on 11 reviews

536%
427%
336%
20%
10%
Ask AI

Ask AI about Sophiris Bio

Generated with AI from 11 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Mark Hardiek
Reviews 1

I've been a customer of Sophiris Bio for several months now, and I must say, their services have greatly exceeded my expectations. The team is knowledgeable, professional, and always goes above and beyond to ensure customer satisfaction. Keep up the good work!

Charles Rawsthorne
Reviews 1

I recently used the services provided by a certain company, and I must say, I'm really impressed. Their team was very helpful throughout the process, and they delivered results that were beyond my expectations. I would definitely recommend their services!

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website โ€” a simple way to convert your visitors into customers.

Get the widget for your site →

About Sophiris Bio

Sophiris Bio Inc. (NASDAQ: SPHS) is a biopharmaceutical company developing a clinical-stage, targeted treatment for the symptoms of benign prostatic hyperplasia (BPH or enlarged prostate), which it believes is an unsatisfied patient population with significant market potential. Sophiris is currently developing PRX302 for the treatment of BPH symptoms which is designed to be as efficacious as pharmaceuticals, less invasive than the surgical interventions, and without the sexual side effects seen with existing treatments. PRX302 is currently in Phase 3 clinical development with a blinded interim analysis expected in the second half of 2014 followed by a complete data analysis in the second half of 2015. For more information, please visit www.sophiris.com.